Composite
38%
Novelty
Feasibility
Impact
Mechanistic
75%
Druggability
50%
Safety
45%
Confidence
26%

Mechanistic description

Age-related synaptic dysfunction is characterized by accumulation of damaged organelles and misfolded proteins due to compromised autophagy-lysosomal pathway efficiency. While TFEB activation increases lysosomal biogenesis, the critical bottleneck in aged synapses may be the impaired fusion between autophagosomes and lysosomes rather than lysosomal abundance alone. This hypothesis proposes that TFEB activation specifically enhances autophagosome-lysosome fusion machinery by upregulating SNARE proteins (STX17, SNAP29, VAMP8) and Rab7 GTPase activity at synaptic terminals. In aged synapses, accumulated oxidative damage disrupts the microtubule network and reduces Rab7-RILP complex formation, preventing efficient autophagosome trafficking to lysosomes. TFEB transcriptionally upregulates not only lysosomal genes but also fusion machinery components, restoring the spatial coupling between autophagosome formation and lysosomal degradation. The intervention would involve targeted TFEB activation through small molecule agonists or optogenetic approaches specifically at synaptic compartments, where the fusion deficit is most pronounced. Evidence would focus on measuring fusion events using dual-fluorescence LC3-LAMP1 assays, monitoring Rab7 activation states, and quantifying SNARE complex formation in aged vs young synaptic preparations. Success would be demonstrated by restored autophagic flux rates, reduced accumulation of p62/SQSTM1 aggregates, and improved synaptic transmission efficiency in aged neurons following TFEB activation.

Evidence for (6)

  • TFEB overexpression reduces tau aggregation and Aβ toxicity in cellular models

  • Impaired TFEB nuclear localization observed in AD brain tissue with mTOR hyperactivation

  • Trehalose enhances lysosomal biogenesis and reduces protein aggregates in neurodegeneration models

  • Autophagosome accumulation in AD synapses indicates upstream autophagy initiation is intact but downstream lysosomal degradation is blocked

  • mTOR inhibitors (rapamycin analogs) enable TFEB nuclear translocation

  • TFEB activation bypasses upstream mTOR dysregulation and directly enhances lysosomal gene expression

Evidence against (6)

  • TFEB regulates hundreds of genes beyond lysosomal biogenesis including lipid metabolism and inflammatory pathways

  • TFEB overexpression paradoxically increases neurodegeneration in α-synuclein models via APP-like substrate processing

  • Global TFEB activation in microglia exacerbates neuroinflammation through enhanced lysosomal antigen presentation

  • TFEB haploinsufficiency is protective in certain aging paradigms, suggesting a 'Goldilocks' principle

  • Trehalose acts as chemical chaperone independently of TFEB

  • Genistein is a broad kinase inhibitor with estrogenic activity

Bayesian persona consensus

55% posterior support

1 signal · 1 for / 0 against · agreement 100%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.